Browsing by Author "Thapaliya, Sabin"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
Publication Essential Thrombocythemia among Patients with Myeloproliferative Neoplasms in Haematology Unit of a Tertiary Care Centre: A Descriptive Cross-sectional Study(Nepal Medical Association, 2022) Sah, Sanjit Kumar; Shah, Sangam; Tiwari, Sansar Babu; Poudel, Basanta Sharma; Singh, Biranmol; Sharma, Prakash; Acharya, Sunil Sharma; Murarka, Hritik; Thapaliya, Sabin; Shrestha, AnjanAbstract Introduction: Essential thrombocythemia, a myeloproliferative condition with an increased number of circulating platelets, is a rare hematological malignancy. The aim of the study is to find out the prevalence of essential thrombocythemia among patients with myeloproliferative neoplasms presenting in haematology unit of a tertiary care centre. Methods: This was a descriptive cross-sectional study at a tertiary care centre from September, 2020 to September, 2021 (Reference number: 48 (6-11) E2077/076). All the patients with a diagnosis of essential thrombocythemia and willing to give consent were included in the study while the patients with incomplete investigations were excluded. A sample size of 72 patients was taken and convenience sampling was done. Data were entered in Microsoft Excel 2010 and analysis was done by the Statistical Package for the Social Sciences Version 22.0. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data along with mean and standard deviation for continuous data. Results: Among 72 patients with myeloproliferative neoplasms, the prevalence of essential thrombocythemia was found to be 17 (23.61%) (13.80-33.42 at a 95% Confidence Interval). The mean age of patients was 55.41±11.20 years with a male to female ratio of 9:8. The mean hemoglobin level and platelet count in patients were found to be 11.20±2.1 g/dl and 677000±262067.70 cells/mm3. Twelve (70.58%) of total patients were under low risk of essential thrombocythemia while 3 (17.64%) of them were at high risk. Conclusions: The prevalence of essential thrombocythemia was similar to other studies done in similar settings.Publication Essential Thrombocythemia among Patients with Myeloproliferative Neoplasms in Haematology Unit of a Tertiary Care Centre: A Descriptive Cross-sectional Study(Nepal Medical Association, 2022) Sah, Sanjit Kumar; Shah, Sangam; Tiwari, Sansar Babu; Poudel, Basanta Sharma; Singh, Biranmol; Sharma, Prakash; Acharya, Sunil Sharma; Murarka, Hritik; Thapaliya, Sabin; Shrestha, AnjanAbstract: Introduction: Essential thrombocythemia, a myeloproliferative condition with an increased number of circulating platelets, is a rare hematological malignancy. The aim of the study is to find out the prevalence of essential thrombocythemia among patients with myeloproliferative neoplasms presenting in haematology unit of a tertiary care centre. Methods: This was a descriptive cross-sectional study at a tertiary care centre from September, 2020 to September, 2021 (Reference number: 48 (6-11) E2077/076). All the patients with a diagnosis of essential thrombocythemia and willing to give consent were included in the study while the patients with incomplete investigations were excluded. A sample size of 72 patients was taken and convenience sampling was done. Data were entered in Microsoft Excel 2010 and analysis was done by the Statistical Package for the Social Sciences Version 22.0. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data along with mean and standard deviation for continuous data. Results: Among 72 patients with myeloproliferative neoplasms, the prevalence of essential thrombocythemia was found to be 17 (23.61%) (13.80-33.42 at a 95% Confidence Interval). The mean age of patients was 55.41±11.20 years with a male to female ratio of 9:8. The mean hemoglobin level and platelet count in patients were found to be 11.20±2.1 g/dl and 677000±262067.70 cells/mm3. Twelve (70.58%) of total patients were under low risk of essential thrombocythemia while 3 (17.64%) of them were at high risk. Conclusions: The prevalence of essential thrombocythemia was similar to other studies done in similar settings.Publication Old World Mucosal Leishmaniasis Treated with a Single Dose of Amphotericin: A Case Report(Institute of Medicine, 2024) Thapaliya, Sabin; Poudyal, Prasanta; Tripathi, Prashant; Thapa, Milan; Anjan, ShresthaABSTRACT Mucosal leishmaniasis, an uncommon disease in the old world, is recognized as an occasional complication of donovani related visceral leishmaniasis. It usually affects the spleen, liver, skin, mucosa of the respiratory tract and, less commonly, the oral cavity. Our case was a young adult with non-healing lesions in the oropharyngeal region who was diagnosed as mucosal leishmaniasis during evaluation for suspected mucosal carcinoma. The diagnosis was made with the rK39 strip-test after multiple futile test results. A single dose of liposomal amphotericin B cured the disease. Keywords: Leishmania donovani; leishmaniasis; mucosalPublication Pharmacotherapy of Hospitalized Patients with COVID-19 at a Tertiary Care Hospital in Nepal(Institute of Medicine, Tribhuvan University, 2025) Mudvari, Anish; Prasad, Pravin; Pokharel, Akritee; Thapaliya, Sabin; Maharjan, Bindira; Khadka, Rebanta; Lamsal, Arun Batsa; Ghimire, Ranjeet; Bista, ApekshaABSTRACT: Introduction The COVID-19 pandemic poses a major health threat with no standardized treatments for SARS-CoV-2. This study evaluates pharmacotherapy trends in COVID-19 patients during the second wave at a tertiary care facility. Methods A retrospective, observational, cross-sectional study was conducted in a tertiary care centre, utilising patient data from April 2021 to July 2021. The sample included 310 patients admitted with a confirmed diagnosis of COVID-19. Patients were classified based on oxygen requirement levels, and data were analysed using descriptive statistics. Results Of the 310 patients, 59% were male and 41% female, with a mean age of 53.37 ± 17.01 years. The average hospital stay was 10 ± 7.15 days. Most patients (66.8%) required supplemental oxygen, and 7.4% required mechanical ventilation. The majority received antibacterial therapy (307, 99.03%), with ceftriaxone being the most commonly prescribed antibiotic (73.22%). Remdesivir was the predominant antiviral, and dexamethasone was used in 88.39% of patients. Conclusion Antibiotic use was extensive among hospitalised COVID-19 patients, with ceftriaxone being the most common. Antiviral use was less frequent, with Remdesivir being the preferred choice. Dexamethasone played a crucial role in managing severe cases.Publication Ulcerative Colitis with Superior Sagittal Sinus Thrombosis: A Case Report(Nepal Medical Association, 2023) Basnet, Somika; Bhandari, Abashesh; Basnet, Bhupendra Kumar; Thapaliya, SabinAbstract Ulcerative colitis is a chronic inflammatory, idiopathic, condition of the mucosa of the colon. Cerebral venous thrombosis is one of the serious and rare complications of inflammatory bowel disease. We report a case of a 27-year-old female patient with complaints of loose stool 5 to 6 episodes per day mixed with blood for 10 days. The patient has severe per rectal bleed, not controlled despite adequate measures and a few days later developed altered sensorium and fits. This case highlights prompt diagnosis and early treatment managing both severe ulcerative colitis and sagittal venous thrombosis. Immediate recognition of her disease improved her condition drastically and increased her survival.